RACHEL HIATT: Open Payments
NPI 1740942606 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $1,762
Food & beverage: $998Travel & lodging: $764
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $919 |
| Otsuka America Pharmaceutical, Inc. | 2 | $238 |
| Vanda Pharmaceuticals Inc. | 2 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| ABBVIE INC. | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $101 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, ABILIFY MAINTENA, FANAPT, UZEDY, VRAYLAR, COBENFY, INGREZZA.
Industry payments across CO — which companies pay providers there.
